For instance, Sun et al. developed a dual-modified cationic liposome system loaded with PTX and survivin siRNA, combining Angiopep-2 (LRP ligand) and the RNA aptamer A15 targeting CD133, which efficiently crosses the BBB and delivers drugs to CD133 cancer stem cells in gliomas [176]. The gene discussed is PROM1; the disease is cancer.